Cutting-edge approaches such as immunotherapy and novel modalities target previously untreatable cancers — driving a new era of oncology therapeutics.
-
Making the ‘Undruggable’ Druggable: A New Path in Cancer Treatment
-
Enhancing Cancer Immunotherapy Through In Situ Editing of Tumor Cell Membranes
-
A New Era of Targeted Therapy: Innovative Breakthroughs in Antibody-Drug Conjugates (ADCs)
-
ADCs Advanced: Engineered Antibodies, Smart Linkers & Multi-Dimensional Targeting Strategies
-
Revolutionizing Cancer Therapy: Multi-Mechanism Payloads & Smart Delivery Systems in ADCs
-
Beyond Precision: Exacting DAR Control and the Chemical Art of ADC Linkers